Search research articles
Contact Us
Filters
Showing results (291-300 of 357) with videos related to
Page
of 36
Sort By:
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|
August 2, 2021
HPDL deficiency causes a neuromuscular disease by impairing the mitochondrial respiration
Yu Sun, Xiujuan Wei, Fang Fang, et al.
Annals of Hematology
|
April 2, 2014
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
Shang-Yi Huang, Chung-Wu Lin, Hsiu-Hsia Lin, et al.
Clinical Hematology International
|
August 11, 2025
Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group
Wenming Chen, Zhen Cai, Chor Sang Chim, et al.
European Journal of Haematology
|
July 12, 2024
An open-label, first-in-human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma
Prashant Kapoor, Nitya Nathwani, Tomas Jelinek, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 26, 2016
A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan
Shang-Yi Huang, Yuan-Bin Yu, Su-Peng Yeh, et al.
Clinical Hematology International
|
May 8, 2026
Guidelines and consensus for minimal residual disease-adapted therapy in multiple myeloma from the Pan-Pacific multiple myeloma working group
Wenming Chen, Zhen Cai, Chor Sang Chim, et al.
Haematologica
|
February 1, 2024
Isatuximab-pomalidomide-dexamethasone <i>versus</i> pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
Paul G Richardson, Aurore Perrot, Jesus San Miguel, et al.
BMC Cancer
|
May 3, 2015
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
Chieh-Lung Cheng, Chi-Cheng Li, Hsin-An Hou, et al.
Mycoses
|
September 20, 2018
The epidemiology of non-Candida yeast isolated from blood: The Asia Surveillance Study
Shang-Yi Lin, Po-Liang Lu, Ban Hock Tan, et al.
Genomics
|
July 23, 2013
HIVID: an efficient method to detect HBV integration using low coverage sequencing
Weiyang Li, Xi Zeng, Nikki P Lee, et al.
Page
of 36
Search research articles
Search
Showing results (291-300 of 357) with videos related to
Sort By:
Page
of 36
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|
August 2, 2021
HPDL deficiency causes a neuromuscular disease by impairing the mitochondrial respiration
Yu Sun, Xiujuan Wei, Fang Fang, et al.
Annals of Hematology
|
April 2, 2014
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
Shang-Yi Huang, Chung-Wu Lin, Hsiu-Hsia Lin, et al.
Clinical Hematology International
|
August 11, 2025
Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group
Wenming Chen, Zhen Cai, Chor Sang Chim, et al.
European Journal of Haematology
|
July 12, 2024
An open-label, first-in-human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma
Prashant Kapoor, Nitya Nathwani, Tomas Jelinek, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 26, 2016
A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan
Shang-Yi Huang, Yuan-Bin Yu, Su-Peng Yeh, et al.
Clinical Hematology International
|
May 8, 2026
Guidelines and consensus for minimal residual disease-adapted therapy in multiple myeloma from the Pan-Pacific multiple myeloma working group
Wenming Chen, Zhen Cai, Chor Sang Chim, et al.
Haematologica
|
February 1, 2024
Isatuximab-pomalidomide-dexamethasone <i>versus</i> pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
Paul G Richardson, Aurore Perrot, Jesus San Miguel, et al.
BMC Cancer
|
May 3, 2015
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
Chieh-Lung Cheng, Chi-Cheng Li, Hsin-An Hou, et al.
Mycoses
|
September 20, 2018
The epidemiology of non-Candida yeast isolated from blood: The Asia Surveillance Study
Shang-Yi Lin, Po-Liang Lu, Ban Hock Tan, et al.
Genomics
|
July 23, 2013
HIVID: an efficient method to detect HBV integration using low coverage sequencing
Weiyang Li, Xi Zeng, Nikki P Lee, et al.
Page
of 36